⚕ GalenOps CRO console
← 708 (USA)

708-1253

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 708 (USA) (Dr. Kim) · consented 2013-05-07
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild CONJUNCTIVITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-06 (study day -1.0); relationship: NONE

mild assessed 2026-08-18

Mild CONJUNCTIVITIS — outcome: RECOVERED/RESOLVED; onset 2013-05-06 (study day -1.0); relationship: NONE

mild assessed 2026-08-18

Mild COUGH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-06 (study day -1.0); relationship: NONE

mild assessed 2026-08-18

Mild COUGH — outcome: RECOVERED/RESOLVED; onset 2013-05-06 (study day -1.0); relationship: NONE

mild assessed 2026-08-18

Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-07 (study day 32.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-06-07 (study day 32.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild HEART RATE INCREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-07 (study day 1.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild HEART RATE INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-05-07 (study day 1.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.